HJ Bogaard: The Most Important Target of Therapy in Advanced WHO Category 1 Pulmonary Hypertension is the Right Ventricle

All credit to Dr. HJ Bogaard FPVRI, VU Medisch Centrum, Amsterdam, The Netherlands

A presentation from the 5th Joint SAPH/PVRI Annual Meeting in Istanbul, 24-27th April 2012

Additional key-words: therapy,pro-con,right heart,Sugen Hypoxia

About the author

Harm-Jan Bogaard

VU University Medical Center Amsterdam

Netherlands

About the author

Harm-Jan Bogaard

VU University Medical Center Amsterdam

Netherlands

Latest PVD abstracts from PubMed

"A priori" Dietary Patterns and Cognitive Function in the SUN Project.

Authors: Munoz-Garcia MI, Toledo E, Razquin C, Dominguez LJ, Maragarone D, Martinez-Gonzalez J, Martinez-Gonzalez MA Source: Neuroepidemiology

Relation of Hepatic Venous Doppler Sonography and Portal Flowmetry in Determination of Severity of Esophageal Varices in Liver Cirrhosis.

Authors: Sangma MA, Biswas N, Paul P Source: Mymensingh Med J

Transposable temperate phages promote the evolution of divergent social strategies in <i>Pseudomonas aeruginosa</i> populations.

Authors: O'Brien S, Kümmerli R, Paterson S, Winstanley C, Brockhurst MA Source: Proc Biol Sci

Second IVIg course in Guillain-Barré syndrome with poor prognosis: the non-randomised ISID study.

Authors: Verboon C, van den Berg B, Cornblath DR, Venema E, Gorson KC, Lunn MP, Lingsma H, Van den Bergh P, Harbo T, Bateman K, Pereon Y, Sindrup SH, Kusunoki S, Miller J, Islam Z, Hartung HP, Chavada G, Jacobs BC, Hughes RAC, van Doorn PA Source: J Neurol Neurosurg Psychiatry

Retinal detachment following cataract phacoemulsification-a review of the literature.

Authors: Qureshi MH, Steel DHW Source: Eye (Lond)

Our research platform is the world.

Through worldwide collaboration, we can begin to answer the question of a global disease.

Join the PVRI

About the author

Harm-Jan Bogaard

More from this author

Related Content

{{GlobalController.truncateTitle("Right ventricular systolic pressure (RVSP) of hypoxic mutant (D849N) mice receiving imatinib.", 65)}}

{{GlobalController.truncateTitle("Right ventricular hypertrophy in hypoxic mutant (D849N) mice receiving imatinib", 65)}}

{{GlobalController.truncateTitle("Muscularization of pulmonary vessels in hypoxic mutant (D849N) mice receiving imatinib", 65)}}

{{GlobalController.truncateTitle("Riociguat and sildenafil attenuate secondary pulmonary hypertension in a model of left heart failure", 65)}}

{{GlobalController.truncateTitle("Clinical evaluation of the RV-PA interaction using pulmonary vascular impedance and pressure-volume loops", 65)}}

Add to reading list

Share this content

Our research platform is the world.